Clinical Trials for Astrocytoma, Grade IV

Find clinical trials for astrocytoma, grade iv. Discover research opportunities and treatment options in your area.

7 Active Trials Found

Showing 7 trials on this page

Page 1 of 1

Safusidenib Phase 2 Study in IDH1 Mutant Glioma

NCT ID: NCT05303519

This clinical trial is studying a new medication called safusidenib to see how well it works for patients with a specific type of brain tumor known as glioma, particularly those with a certain gene...

Recruiting

Phase: PHASE2 Type: interventional Locations: New York, New York, United States, Cleveland, Ohio, United States +8 more

Study of Olutasidenib and Temozolomide in HGG

NCT ID: NCT06161974

This clinical trial is studying the effectiveness of a new treatment combining two drugs, olutasidenib and temozolomide, for young patients recently diagnosed with high-grade glioma (HGG) that has ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Randwick, New South Wales, Australia, Cincinnati, Ohio, United States +18 more

Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Recurrent Glioblastoma or Recurrent Astrocytoma in Patients Undergoing Craniotomy

NCT ID: NCT05789394

This clinical trial is exploring the safety and effectiveness of using special cells called adipose-derived mesenchymal stem cells (AMSCs) to treat patients with recurrent glioblastoma or astrocyto...

Recruiting

Phase: PHASE1 Type: interventional Locations: Jacksonville, Florida, United States

T Cells and Pembrolizumab for Recurrent and Newly Diagnosed Glioblastoma

NCT ID: NCT06157541

This clinical trial is investigating a new treatment approach for patients with a serious type of brain cancer called glioblastoma multiforme, also known as grade IV astrocytoma. The study is testi...

Recruiting

Phase: PHASE1 Type: interventional Locations: Heidelberg, Victoria, Australia, Woolloongabba, Queensland, Australia +2 more

The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)

NCT ID: NCT06118723

The SUPRAMAX Study is researching the effects of two different surgical approaches for treating patients with high-grade gliomas, which are aggressive types of brain tumors. Specifically, the study...

Recruiting

Type: observational Locations: Boston, Massachusetts, United States, Heidelberg, , Germany +7 more

The SAFE-Trial: Awake Craniotomy Versus Surgery Under General Anesthesia for Glioblastoma Patients.

NCT ID: NCT03861299

The SAFE-Trial is a clinical study comparing two types of brain surgery for patients with glioblastoma, a type of aggressive brain cancer. The study will involve 246 patients who have tumors locate...

Recruiting

Phase: NA Type: interventional Locations: Groningen, , Netherlands, Ghent, , Belgium +3 more

Coaching for Coping in Glioblastoma Patients and Caregivers and Its Association With Compliance to TTFields

NCT ID: NCT06017063

This clinical trial, called "Coaching for Coping in Glioblastoma Patients and Caregivers," is designed to help patients with glioblastoma and their caregivers better follow their treatment plan usi...

Not yet recruiting

Phase: NA Type: interventional

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions